Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid
Clinical trial NCT00729924 · COMPLETED
Trial details
- NCT number
- NCT00729924
- Sponsor
- Vanderbilt University
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2011-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.